Share Price and Basic Stock Data
Last Updated: November 4, 2025, 5:31 pm
| PEG Ratio | 2.41 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Royal Orchid Hotels Ltd operates within the Hotels, Resorts & Restaurants industry, recording a price of ₹490 and a market capitalization of ₹1,344 Cr. The company has demonstrated a consistent upward trajectory in revenue, with sales rising from ₹139 Cr in FY 2022 to ₹264 Cr in FY 2023, and further to ₹294 Cr in FY 2024. For the trailing twelve months (TTM), sales stood at ₹325 Cr. Quarterly sales trends show fluctuations, with the highest quarterly sales of ₹89 Cr recorded in December 2024, while the lowest was ₹58 Cr in September 2022. This suggests seasonal variances, typical in the hospitality sector, influenced by tourism patterns and economic conditions. The company’s operational performance is reflected in its operating profit margin (OPM), which peaked at 35% in June 2022 but has seen a gradual decline to 25% in June 2025. This decline may indicate increasing operational costs or competitive pressures impacting profitability.
Profitability and Efficiency Metrics
Royal Orchid Hotels reported a net profit of ₹50 Cr, translating to a net profit margin of 13.49% for FY 2025. The company’s return on equity (ROE) stood at an impressive 22.4%, while the return on capital employed (ROCE) was recorded at 17.4%. The interest coverage ratio (ICR) of 5.84x indicates a strong ability to cover interest expenses, suggesting robust profitability relative to debt obligations. However, quarterly net profit figures reveal variability, with a high of ₹18 Cr in December 2024 and a low of ₹8 Cr in September 2023. Efficiency metrics, such as the cash conversion cycle (CCC) of 42 days, indicate a manageable period for turning investments into cash flow. Nonetheless, the declining operating profit margin from 35% to 25% over three years highlights potential challenges in sustaining profitability amid rising costs or competitive pricing pressures.
Balance Sheet Strength and Financial Ratios
The balance sheet of Royal Orchid Hotels reflects a mix of strength and potential vulnerabilities. As of FY 2025, total borrowings amounted to ₹221 Cr against reserves of ₹203 Cr, suggesting a leveraged position. The debt-to-equity ratio stood at 0.43, indicating moderate leverage relative to equity. Additionally, the company reported a current ratio of 1.24 and a quick ratio of 1.21, both of which are above the typical sector benchmarks, reflecting a sound liquidity position. The book value per share increased to ₹84.16 in FY 2025, up from ₹53.61 in FY 2022, indicating strengthening shareholder equity. However, the price-to-book value ratio of 4.66x suggests that the stock may be trading at a premium compared to its book value, which could be a concern for value-oriented investors. Overall, the financial ratios indicate a solid foundation, but the reliance on debt and high market valuation may pose risks.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Royal Orchid Hotels reveals a strong promoter holding of 63.89%, indicating significant insider confidence in the company’s future. Foreign institutional investors (FIIs) have gradually increased their stake to 7.72%, reflecting growing interest from external investors. Domestic institutional investors (DIIs) hold a smaller portion at 0.80%. The public shareholding stands at 27.59%, with the number of shareholders increasing to 26,590, indicating growing retail interest. However, the slight decline in public shareholding from 32.21% in September 2023 to 27.59% in June 2025 may raise concerns about retail investor sentiment. The consistency in promoter holdings, combined with increasing FII participation, suggests a stable investor base, although the decline in public stake could reflect market apprehensions or profit-taking behavior among retail investors.
Outlook, Risks, and Final Insight
Royal Orchid Hotels is positioned in a recovering hospitality sector, with potential for growth driven by increasing travel demand and improved operational efficiency. However, the company faces notable risks including rising operational costs, competitive pricing pressures, and reliance on debt financing, which could impact profitability. Additionally, fluctuations in quarterly earnings may create volatility in investor sentiment. The company’s ability to sustain its profitability amid these pressures will be crucial. Should operational efficiencies improve or market conditions favor hospitality recovery, Royal Orchid could capitalize on growth opportunities. Conversely, if rising costs persist without corresponding revenue growth, it may face challenges in maintaining its profit margins and investor confidence. Continuous monitoring of operational metrics and market conditions will be essential for assessing the company’s trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Royal Orchid Hotels Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Howard Hotels Ltd | 22.3 Cr. | 24.5 | 33.9/20.7 | 30.6 | 12.6 | 0.00 % | 6.09 % | 3.55 % | 10.0 |
| HS India Ltd | 21.9 Cr. | 13.5 | 19.7/11.2 | 15.1 | 19.6 | 0.00 % | 7.04 % | 4.51 % | 10.0 |
| Gujarat Hotels Ltd | 88.5 Cr. | 234 | 375/205 | 15.0 | 132 | 1.28 % | 15.0 % | 11.4 % | 10.0 |
| Graviss Hospitality Ltd | 271 Cr. | 38.4 | 78.0/37.0 | 34.4 | 27.3 | 0.00 % | 1.18 % | 4.70 % | 2.00 |
| Goel Food Products Ltd | 27.8 Cr. | 14.8 | 33.5/13.2 | 5.50 | 11.8 | 0.00 % | 17.8 % | 22.8 % | 10.0 |
| Industry Average | 9,788.80 Cr | 499.41 | 306.90 | 101.91 | 0.24% | 12.63% | 10.42% | 6.81 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 60 | 58 | 72 | 73 | 69 | 67 | 82 | 76 | 73 | 70 | 89 | 87 | 79 |
| Expenses | 39 | 43 | 49 | 51 | 51 | 51 | 57 | 58 | 56 | 59 | 64 | 67 | 59 |
| Operating Profit | 21 | 15 | 24 | 22 | 18 | 15 | 25 | 18 | 17 | 11 | 25 | 20 | 20 |
| OPM % | 35% | 26% | 33% | 30% | 26% | 23% | 30% | 23% | 23% | 16% | 28% | 23% | 25% |
| Other Income | 3 | 5 | 4 | 4 | 5 | 3 | 5 | 6 | 5 | 8 | 6 | 6 | 4 |
| Interest | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 |
| Depreciation | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | 16 | 12 | 19 | 16 | 14 | 10 | 20 | 14 | 12 | 10 | 22 | 16 | 15 |
| Tax % | 26% | 26% | 27% | 26% | 25% | 22% | 27% | -7% | 27% | 31% | 24% | 30% | 26% |
| Net Profit | 12 | 9 | 15 | 13 | 11 | 8 | 16 | 17 | 9 | 8 | 18 | 13 | 11 |
| EPS in Rs | 4.03 | 3.22 | 5.27 | 4.62 | 3.53 | 2.49 | 5.60 | 6.06 | 3.21 | 2.73 | 6.49 | 4.79 | 3.99 |
Last Updated: August 20, 2025, 4:25 am
Below is a detailed analysis of the quarterly data for Royal Orchid Hotels Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 87.00 Cr. (Mar 2025) to 79.00 Cr., marking a decrease of 8.00 Cr..
- For Expenses, as of Jun 2025, the value is 59.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 67.00 Cr. (Mar 2025) to 59.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
- For OPM %, as of Jun 2025, the value is 25.00%. The value appears strong and on an upward trend. It has increased from 23.00% (Mar 2025) to 25.00%, marking an increase of 2.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Mar 2025) to 26.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.99. The value appears to be declining and may need further review. It has decreased from 4.79 (Mar 2025) to 3.99, marking a decrease of 0.80.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:10 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 142 | 148 | 159 | 175 | 189 | 204 | 205 | 81 | 139 | 264 | 294 | 319 | 325 |
| Expenses | 121 | 127 | 138 | 155 | 158 | 169 | 174 | 92 | 115 | 182 | 218 | 246 | 249 |
| Operating Profit | 21 | 21 | 21 | 20 | 32 | 35 | 31 | -11 | 24 | 82 | 76 | 73 | 76 |
| OPM % | 15% | 14% | 13% | 11% | 17% | 17% | 15% | -14% | 17% | 31% | 26% | 23% | 23% |
| Other Income | -32 | 4 | 5 | 13 | 9 | 15 | 15 | 1 | 42 | 16 | 19 | 24 | 23 |
| Interest | 19 | 16 | 15 | 16 | 16 | 14 | 16 | 16 | 17 | 16 | 18 | 17 | 16 |
| Depreciation | 14 | 15 | 14 | 16 | 16 | 14 | 19 | 19 | 19 | 18 | 20 | 21 | 21 |
| Profit before tax | -44 | -6 | -3 | 0 | 9 | 21 | 11 | -46 | 30 | 64 | 57 | 59 | 62 |
| Tax % | -9% | 17% | 30% | 3,892% | 74% | 38% | 53% | -13% | 10% | 26% | 17% | 28% | |
| Net Profit | -40 | -7 | -4 | -5 | 2 | 13 | 5 | -40 | 27 | 49 | 51 | 47 | 50 |
| EPS in Rs | -13.77 | -1.42 | -0.48 | -1.67 | 1.23 | 4.36 | 1.79 | -11.84 | 10.71 | 17.15 | 17.68 | 17.23 | 18.00 |
| Dividend Payout % | -1% | 0% | 0% | -60% | 122% | 46% | 0% | 0% | 0% | 12% | 14% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 82.50% | 42.86% | -25.00% | 140.00% | 550.00% | -61.54% | -900.00% | 167.50% | 81.48% | 4.08% | -7.84% |
| Change in YoY Net Profit Growth (%) | 0.00% | -39.64% | -67.86% | 165.00% | 410.00% | -611.54% | -838.46% | 1067.50% | -86.02% | -77.40% | -11.92% |
Royal Orchid Hotels Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 9% |
| 3 Years: | 32% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 57% |
| 3 Years: | 90% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 50% |
| 3 Years: | 27% |
| 1 Year: | 51% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 15% |
| 3 Years: | 26% |
| Last Year: | 22% |
Last Updated: September 5, 2025, 1:10 pm
Balance Sheet
Last Updated: June 16, 2025, 11:26 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 144 | 135 | 133 | 139 | 142 | 150 | 146 | 113 | 98 | 146 | 163 | 203 |
| Borrowings | 133 | 91 | 82 | 112 | 106 | 102 | 152 | 163 | 149 | 158 | 200 | 221 |
| Other Liabilities | 91 | 92 | 100 | 130 | 126 | 124 | 124 | 115 | 89 | 93 | 79 | 86 |
| Total Liabilities | 395 | 346 | 342 | 408 | 402 | 403 | 449 | 419 | 362 | 423 | 470 | 538 |
| Fixed Assets | 269 | 248 | 238 | 286 | 272 | 264 | 307 | 243 | 193 | 206 | 255 | 253 |
| CWIP | 17 | 20 | 22 | 22 | 21 | 21 | 21 | 1 | 0 | 1 | 0 | 17 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 | 27 | 30 | 34 |
| Other Assets | 109 | 78 | 82 | 100 | 108 | 118 | 120 | 175 | 145 | 190 | 184 | 234 |
| Total Assets | 395 | 346 | 342 | 408 | 402 | 403 | 449 | 419 | 362 | 423 | 470 | 538 |
Below is a detailed analysis of the balance sheet data for Royal Orchid Hotels Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
- For Reserves, as of Mar 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from 163.00 Cr. (Mar 2024) to 203.00 Cr., marking an increase of 40.00 Cr..
- For Borrowings, as of Mar 2025, the value is 221.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 200.00 Cr. (Mar 2024) to 221.00 Cr., marking an increase of 21.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 86.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79.00 Cr. (Mar 2024) to 86.00 Cr., marking an increase of 7.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 538.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 470.00 Cr. (Mar 2024) to 538.00 Cr., marking an increase of 68.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 253.00 Cr.. The value appears to be declining and may need further review. It has decreased from 255.00 Cr. (Mar 2024) to 253.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Mar 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 17.00 Cr., marking an increase of 17.00 Cr..
- For Investments, as of Mar 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2024) to 34.00 Cr., marking an increase of 4.00 Cr..
- For Other Assets, as of Mar 2025, the value is 234.00 Cr.. The value appears strong and on an upward trend. It has increased from 184.00 Cr. (Mar 2024) to 234.00 Cr., marking an increase of 50.00 Cr..
- For Total Assets, as of Mar 2025, the value is 538.00 Cr.. The value appears strong and on an upward trend. It has increased from 470.00 Cr. (Mar 2024) to 538.00 Cr., marking an increase of 68.00 Cr..
However, the Borrowings (221.00 Cr.) are higher than the Reserves (203.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -112.00 | -70.00 | -61.00 | -92.00 | -74.00 | -67.00 | -121.00 | -174.00 | -125.00 | -76.00 | -124.00 | -148.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 32 | 38 | 35 | 39 | 45 | 33 | 41 | 43 | 55 | 44 | 41 | 42 |
| Inventory Days | 42 | 39 | 38 | 37 | 41 | 40 | 33 | 52 | 41 | 31 | ||
| Days Payable | 313 | 500 | 527 | 553 | 573 | 585 | 491 | 1,102 | 807 | 507 | ||
| Cash Conversion Cycle | -239 | -423 | -454 | -477 | -487 | -512 | -417 | -1,006 | -712 | -432 | 41 | 42 |
| Working Capital Days | -211 | -133 | -134 | -105 | -92 | -101 | -105 | -73 | -111 | -49 | -48 | -40 |
| ROCE % | 3% | 3% | 4% | 5% | 8% | 11% | 8% | -6% | 7% | 25% | 20% | 17% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 17.23 | 17.68 | 17.15 | 10.71 | -11.84 |
| Diluted EPS (Rs.) | 17.23 | 17.68 | 17.15 | 10.71 | -11.84 |
| Cash EPS (Rs.) | 23.28 | 24.51 | 23.81 | 16.86 | -7.56 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 84.16 | 75.88 | 71.84 | 53.61 | 63.08 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 84.16 | 75.88 | 71.84 | 53.61 | 63.08 |
| Revenue From Operations / Share (Rs.) | 116.49 | 107.06 | 96.10 | 50.51 | 29.48 |
| PBDIT / Share (Rs.) | 35.29 | 34.70 | 35.74 | 14.72 | -1.13 |
| PBIT / Share (Rs.) | 27.73 | 27.45 | 29.04 | 7.63 | -8.17 |
| PBT / Share (Rs.) | 21.69 | 20.80 | 23.19 | 10.89 | -16.78 |
| Net Profit / Share (Rs.) | 15.73 | 17.27 | 17.11 | 9.77 | -14.59 |
| NP After MI And SOA / Share (Rs.) | 17.23 | 17.68 | 17.15 | 10.71 | -11.84 |
| PBDIT Margin (%) | 30.29 | 32.41 | 37.19 | 29.13 | -3.84 |
| PBIT Margin (%) | 23.80 | 25.64 | 30.22 | 15.09 | -27.70 |
| PBT Margin (%) | 18.61 | 19.42 | 24.13 | 21.56 | -56.91 |
| Net Profit Margin (%) | 13.49 | 16.13 | 17.81 | 19.33 | -49.49 |
| NP After MI And SOA Margin (%) | 14.78 | 16.51 | 17.84 | 21.19 | -40.16 |
| Return on Networth / Equity (%) | 20.46 | 25.42 | 27.18 | 23.45 | -23.13 |
| Return on Capital Employeed (%) | 17.32 | 19.75 | 23.15 | 7.32 | -7.03 |
| Return On Assets (%) | 8.77 | 10.31 | 11.09 | 8.09 | -7.75 |
| Long Term Debt / Equity (X) | 0.34 | 0.24 | 0.37 | 0.57 | 0.67 |
| Total Debt / Equity (X) | 0.43 | 0.35 | 0.43 | 0.64 | 0.69 |
| Asset Turnover Ratio (%) | 0.63 | 0.65 | 0.67 | 0.35 | 0.12 |
| Current Ratio (X) | 1.24 | 1.31 | 1.67 | 1.28 | 1.29 |
| Quick Ratio (X) | 1.21 | 1.28 | 1.64 | 1.25 | 1.27 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 11.31 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 8.02 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 88.69 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 91.98 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 5.84 | 5.21 | 6.11 | 2.51 | -0.19 |
| Interest Coverage Ratio (Post Tax) (X) | 3.60 | 3.59 | 3.92 | 1.11 | -1.00 |
| Enterprise Value (Cr.) | 1134.82 | 1026.79 | 770.23 | 390.36 | 257.57 |
| EV / Net Operating Revenue (X) | 3.55 | 3.50 | 2.92 | 2.82 | 3.19 |
| EV / EBITDA (X) | 11.73 | 10.79 | 7.86 | 9.67 | -82.79 |
| MarketCap / Net Operating Revenue (X) | 3.37 | 3.38 | 2.82 | 2.42 | 2.13 |
| Retention Ratios (%) | 0.00 | 88.68 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 4.66 | 5.21 | 4.29 | 2.68 | 1.23 |
| Price / Net Operating Revenue (X) | 3.37 | 3.38 | 2.82 | 2.42 | 2.13 |
| EarningsYield | 0.04 | 0.04 | 0.06 | 0.08 | -0.18 |
After reviewing the key financial ratios for Royal Orchid Hotels Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has decreased from 17.68 (Mar 24) to 17.23, marking a decrease of 0.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has decreased from 17.68 (Mar 24) to 17.23, marking a decrease of 0.45.
- For Cash EPS (Rs.), as of Mar 25, the value is 23.28. This value is within the healthy range. It has decreased from 24.51 (Mar 24) to 23.28, marking a decrease of 1.23.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.16. It has increased from 75.88 (Mar 24) to 84.16, marking an increase of 8.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.16. It has increased from 75.88 (Mar 24) to 84.16, marking an increase of 8.28.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 116.49. It has increased from 107.06 (Mar 24) to 116.49, marking an increase of 9.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.29. This value is within the healthy range. It has increased from 34.70 (Mar 24) to 35.29, marking an increase of 0.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 27.73. This value is within the healthy range. It has increased from 27.45 (Mar 24) to 27.73, marking an increase of 0.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 21.69. This value is within the healthy range. It has increased from 20.80 (Mar 24) to 21.69, marking an increase of 0.89.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.73. This value is within the healthy range. It has decreased from 17.27 (Mar 24) to 15.73, marking a decrease of 1.54.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has decreased from 17.68 (Mar 24) to 17.23, marking a decrease of 0.45.
- For PBDIT Margin (%), as of Mar 25, the value is 30.29. This value is within the healthy range. It has decreased from 32.41 (Mar 24) to 30.29, marking a decrease of 2.12.
- For PBIT Margin (%), as of Mar 25, the value is 23.80. This value exceeds the healthy maximum of 20. It has decreased from 25.64 (Mar 24) to 23.80, marking a decrease of 1.84.
- For PBT Margin (%), as of Mar 25, the value is 18.61. This value is within the healthy range. It has decreased from 19.42 (Mar 24) to 18.61, marking a decrease of 0.81.
- For Net Profit Margin (%), as of Mar 25, the value is 13.49. This value exceeds the healthy maximum of 10. It has decreased from 16.13 (Mar 24) to 13.49, marking a decrease of 2.64.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.78. This value is within the healthy range. It has decreased from 16.51 (Mar 24) to 14.78, marking a decrease of 1.73.
- For Return on Networth / Equity (%), as of Mar 25, the value is 20.46. This value is within the healthy range. It has decreased from 25.42 (Mar 24) to 20.46, marking a decrease of 4.96.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.32. This value is within the healthy range. It has decreased from 19.75 (Mar 24) to 17.32, marking a decrease of 2.43.
- For Return On Assets (%), as of Mar 25, the value is 8.77. This value is within the healthy range. It has decreased from 10.31 (Mar 24) to 8.77, marking a decrease of 1.54.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.34. This value is within the healthy range. It has increased from 0.24 (Mar 24) to 0.34, marking an increase of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has increased from 0.35 (Mar 24) to 0.43, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has decreased from 0.65 (Mar 24) to 0.63, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 1.5. It has decreased from 1.31 (Mar 24) to 1.24, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.21, marking a decrease of 0.07.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.31 (Mar 24) to 0.00, marking a decrease of 11.31.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.02 (Mar 24) to 0.00, marking a decrease of 8.02.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.69 (Mar 24) to 0.00, marking a decrease of 88.69.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.98 (Mar 24) to 0.00, marking a decrease of 91.98.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.84. This value is within the healthy range. It has increased from 5.21 (Mar 24) to 5.84, marking an increase of 0.63.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.60. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 3.60, marking an increase of 0.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,134.82. It has increased from 1,026.79 (Mar 24) to 1,134.82, marking an increase of 108.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.55. This value exceeds the healthy maximum of 3. It has increased from 3.50 (Mar 24) to 3.55, marking an increase of 0.05.
- For EV / EBITDA (X), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 10.79 (Mar 24) to 11.73, marking an increase of 0.94.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 3.38 (Mar 24) to 3.37, marking a decrease of 0.01.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.68 (Mar 24) to 0.00, marking a decrease of 88.68.
- For Price / BV (X), as of Mar 25, the value is 4.66. This value exceeds the healthy maximum of 3. It has decreased from 5.21 (Mar 24) to 4.66, marking a decrease of 0.55.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 3.38 (Mar 24) to 3.37, marking a decrease of 0.01.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Royal Orchid Hotels Ltd:
- Net Profit Margin: 13.49%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.32% (Industry Average ROCE: 12.63%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.46% (Industry Average ROE: 10.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.6
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.4 (Industry average Stock P/E: 306.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.49%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hotels, Resorts & Restaurants | Hotel Royal Orchid: No.1, Golf Avenue, Bengaluru Karnataka 560008 | investors@royalorchidhotels.com http://www.royalorchidhotels.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chander K Baljee | Chairman & Managing Director |
| Mr. Sunil Sikka | Non Executive Director |
| Mr. Keshav Baljee | Non Executive Director |
| Ms. Leena S Pirgal | Independent Director |
| Mr. Rajkumar Thakardas Khatri | Independent Director |
| Mr. Ashutosh Chandra | Independent Director |
FAQ
What is the intrinsic value of Royal Orchid Hotels Ltd?
Royal Orchid Hotels Ltd's intrinsic value (as of 04 November 2025) is 400.45 which is 16.22% lower the current market price of 478.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,306 Cr. market cap, FY2025-2026 high/low of 594/302, reserves of ₹203 Cr, and liabilities of 538 Cr.
What is the Market Cap of Royal Orchid Hotels Ltd?
The Market Cap of Royal Orchid Hotels Ltd is 1,306 Cr..
What is the current Stock Price of Royal Orchid Hotels Ltd as on 04 November 2025?
The current stock price of Royal Orchid Hotels Ltd as on 04 November 2025 is 478.
What is the High / Low of Royal Orchid Hotels Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Royal Orchid Hotels Ltd stocks is 594/302.
What is the Stock P/E of Royal Orchid Hotels Ltd?
The Stock P/E of Royal Orchid Hotels Ltd is 26.4.
What is the Book Value of Royal Orchid Hotels Ltd?
The Book Value of Royal Orchid Hotels Ltd is 84.2.
What is the Dividend Yield of Royal Orchid Hotels Ltd?
The Dividend Yield of Royal Orchid Hotels Ltd is 0.53 %.
What is the ROCE of Royal Orchid Hotels Ltd?
The ROCE of Royal Orchid Hotels Ltd is 17.4 %.
What is the ROE of Royal Orchid Hotels Ltd?
The ROE of Royal Orchid Hotels Ltd is 22.4 %.
What is the Face Value of Royal Orchid Hotels Ltd?
The Face Value of Royal Orchid Hotels Ltd is 10.0.